| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Psa1g5085 | ATGATTCCATTTACCTTCATTTTCTTCACTCTGTTTTCTGTTCTGTTTTCCTCTGTTTTTTCATCCTCCTTGCTTACTGATTTTCATGCTTTGGTCAATCTTAAACAAGGCTTTAAATTCTCAAACCAAATTCTAAACTCATGGGAAGGTCCAAATTTCACTACAGTTTGTTCTTGGGGTGGAATTCAATGCCGCGAGAGTCGAATCGTCTCGGTCGACTTAACCGATTTGAATCTGTTTGGCTCTGTTTCGCCTTCAATCTCATCACTTGATAAACTCACACACCTTTCTCTAGCCGGAAACAACTTCACCGGAACCATTGACCTCACAAACTTAACCAATCTTCAGTTTCTAAACATCTCCAACAACAATTTCAGTGGTAACATGGATTGGAACTTCTCCACCATGCAAAACCTACAAGTCCTTGATGTCTATAACAACAATTTCACTTCATTGCTTCCATTAGGACTTCTTACCTTGAAGCAAAACCTCAAACACTTGGATCTAGGTGGTAACTTTTTCTTCGGCGAAATCCCGAAAAGATTCGGAGAATTCGCTTCTCTTGAGTATCTTTCACTGGCTGGAAATGATATCACAGGAAAAATCCCTGGTGAGTTAGGAAATCTAAGCAACTTGAGAGAAATTTACTTGGGCTATTACAATTCCTTTGAAGGTGGAATTCCGAAAGAGTTTCGAACTTTAACAAACCTTGTTCATATGGATCTTTCAAGCTGTGATTTAGATGGTTCAATCCCAAAAGAGTTAGGTGAATTGAAGAAACTCGATACACTTTACTTGCATATAAACCAGCTTTCAGGTTCATTACCAAAACATCTTGGTAACTTAACAAACCTTCTCTACCTCGATCTTTCGAGCAATGCGCTCACCGGTGAAATTCCATTTGAGTTCATCAATCTCAGAAATCTCAAGCTGTTGAATCTTTTCTTGAACAGGTTACATGGTTCTATACCTGATTACATTGCGGATTTTCCTGATTTAGACACACTTGGTTTATGGATGAACAACTTCACTGGTGAAATTCCATATAAACTTGGTCTCAATGGGAAGATTCAAGTGCTTGATTTGTCTTCTAATAAACTCACTGGTGTTATTCCACCTCATCTTTGTTCTTCAAACCAGCTTAAGATTTTGATTCTTCTTAACAATTTTCTCTTTGGTCCTATACCAGAAGGTTTAGGAACATGTTATAGTCTCACTAGAGTGAGATTAGGAGAGAATTATCTTAATGGAAGTATTCCAAATGGTTTTCTTTATCTTCCTAAGCTAAATTTAGCTGAGTTGAAGAACAATTACTTGTCAGGAACATTGTTAGAAAATGGCAACGGTTCGTCTTCGTTTTCTCAATCTCAATCTCAGCCTGTTTGTTTACAACAGCTTGATTTGTCGAACAATGCTTTGTCTGGTCCTTTACCGCATTCGCTCTCGAATTTCACTTCACTTCAAATACTTTTGCTTAGTGGAAACCAATTTTCGGGTCCGATTCCGAGTTCTATTGGAGGACTTAACCAAGTGTTGAAGCTTGACCTTAGTAGAAACTTGTTATCCGGTGAAATTCCGTCCGAAATCGGAAACTGTGTTCATCTTACCTACCTTGACATGAGCCAGAACAATCTTTCTGGCTCAATTCCGCAATCGTTTTCGGATATTCGTATTTTGAATTACTTGAACTTGTCTAGAAACCATTTGAACCAGACCATACCAAAGTCAATAGGAACAATGAAAAGCCTCACAGTTGCTGATTTCTCCTTCAACGAATTCTCCGGTAAATTGCCCGAATCAGGCCAATTTTCGTTCTTCAACGCGTCCGCGTTCGCGGGGAATCCTAAACTATGTGGCTCTCTATTGAACAATCCATGTAAGTTGACAGGAATGAAATCCACACCAGGAAAAAAAACCAATGCAGATTTCAAGCTGATATTCGCGCTCGGCCTATTGATGTGTTCTTTAGTCTTTGTTATCGCGGCCATTATAAAAGCCAAGTCATTCAAAAAGAATGGTCCTGGTTCTTGGAAGATGACTGCTTTCAAAAAGCTCGAGTTCACCGTTTCAGACATCCTCGAATGCGTGAAAGACGGCAACGTGATCGGAAGAGGAGGCGCAGGGATAGTTTACCACGGAAAAATGCCAAATGGTGTGGAAATTGCAGTAAAAAAACTACTCGGGTTCGGTGCAAATAGCCATGATCATGGTTTTAGAGCTGAAATTCAAACACTTGGAAACATAAGACACAGAAACATAGTGAGGCTACTTGCATTCTGTTCAAACAAAGAAACAAATCTTCTTGTGTATGAGTACATGAGAAATGGAAGCTTAGGTGAAGCATTGCATGGAAAAAAAGGCGCATTCTTGAGTTGGAACTTTCGGTACAAGATATCTATTGATTCTGCTAAAGGACTATGCTATCTTCACCATGATTGTTCTCCATTGATCCTACACAGAGATGTGAAATCTAACAACATTTTGTTGAGTTCGAATTTCGAAGCACATGTTGCTGATTTCGGGCTAGCAAAATTCTTGGTTGATGGTGCCGCATCAGAATGCATGTCTTCCATTGCAGGATCATATGGTTACATTGCACCAGAATATGCATATACATTAAGAGTGGATGAAAAAAGCGATGTGTATAGTTTCGGAGTAGTTCTACTAGAACTTCTAACTGGTAAAAAACCAGTTGGTGATTTTGGAGAAGGTGTAGATCTTGTACAATGGTGCAAAAAAGCAACAAATGGAACAAGAGAACAAGTTATCGACATAATCGATTCAAGACTCATGGTTGTGCCAAAAGAAGAAGCCATGCACATGTTCTTCATTGCAATGCTATGTTTAGAAGAAAACAGTGTTCAAAGACCAACCATGAGAGAAGTTGTTCAGATGCTTTCTGAATTTCCAAGACAATCTTCTTCATGTTCTTCATCTTCTAGTATTAATCCACCAAGCAAAAACTTAATTCAGAATCATAAATTACCTTGTTCTCCTACTTTTAAACATGATCTTTTGGTTTAA | 3024 | 0.3866 | MIPFTFIFFTLFSVLFSSVFSSSLLTDFHALVNLKQGFKFSNQILNSWEGPNFTTVCSWGGIQCRESRIVSVDLTDLNLFGSVSPSISSLDKLTHLSLAGNNFTGTIDLTNLTNLQFLNISNNNFSGNMDWNFSTMQNLQVLDVYNNNFTSLLPLGLLTLKQNLKHLDLGGNFFFGEIPKRFGEFASLEYLSLAGNDITGKIPGELGNLSNLREIYLGYYNSFEGGIPKEFRTLTNLVHMDLSSCDLDGSIPKELGELKKLDTLYLHINQLSGSLPKHLGNLTNLLYLDLSSNALTGEIPFEFINLRNLKLLNLFLNRLHGSIPDYIADFPDLDTLGLWMNNFTGEIPYKLGLNGKIQVLDLSSNKLTGVIPPHLCSSNQLKILILLNNFLFGPIPEGLGTCYSLTRVRLGENYLNGSIPNGFLYLPKLNLAELKNNYLSGTLLENGNGSSSFSQSQSQPVCLQQLDLSNNALSGPLPHSLSNFTSLQILLLSGNQFSGPIPSSIGGLNQVLKLDLSRNLLSGEIPSEIGNCVHLTYLDMSQNNLSGSIPQSFSDIRILNYLNLSRNHLNQTIPKSIGTMKSLTVADFSFNEFSGKLPESGQFSFFNASAFAGNPKLCGSLLNNPCKLTGMKSTPGKKTNADFKLIFALGLLMCSLVFVIAAIIKAKSFKKNGPGSWKMTAFKKLEFTVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGANSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLSWNFRYKISIDSAKGLCYLHHDCSPLILHRDVKSNNILLSSNFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGKKPVGDFGEGVDLVQWCKKATNGTREQVIDIIDSRLMVVPKEEAMHMFFIAMLCLEENSVQRPTMREVVQMLSEFPRQSSSCSSSSSINPPSKNLIQNHKLPCSPTFKHDLLV* | 1008 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Psa1g5085 | 1007 | Gene3D | Ribonuclease Inhibitor | 133 | 219 | IPR032675 | - | |
| Psa1g5085 | 1007 | Gene3D | Ribonuclease Inhibitor | 280 | 356 | IPR032675 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 306 | 330 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 282 | 305 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 556 | 580 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 185 | 209 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 508 | 532 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 136 | 159 | IPR003591 | - | |
| Psa1g5085 | 1007 | SMART | LRR_typ_2 | 234 | 258 | IPR003591 | - | |
| Psa1g5085 | 1007 | ProSiteProfiles | Leucine-rich repeat profile. | 138 | 159 | IPR001611 | GO:0005515 | |
| Psa1g5085 | 1007 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE BAM3 | 7 | 975 | - | - | |
| Psa1g5085 | 1007 | Pfam | Leucine rich repeat | 163 | 219 | IPR001611 | GO:0005515 | |
| Psa1g5085 | 1007 | Pfam | Leucine Rich Repeat | 356 | 376 | IPR001611 | GO:0005515 | |
| Psa1g5085 | 1007 | Pfam | Leucine Rich Repeat | 534 | 554 | IPR001611 | GO:0005515 | |
| Psa1g5085 | 1007 | Pfam | Leucine Rich repeat | 282 | 298 | IPR001611 | GO:0005515 | |
| Psa1g5085 | 1007 | ProSiteProfiles | Protein kinase domain profile. | 696 | 970 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Psa1g5085 | 1007 | Gene3D | Phosphorylase Kinase; domain 1 | 661 | 772 | - | - | |
| Psa1g5085 | 1007 | Pfam | Leucine rich repeat N-terminal domain | 26 | 64 | IPR013210 | - | |
| Psa1g5085 | 1007 | Gene3D | Ribonuclease Inhibitor | 357 | 632 | IPR032675 | - | |
| Psa1g5085 | 1007 | Pfam | Protein tyrosine and serine/threonine kinase | 699 | 966 | IPR001245 | GO:0004672|GO:0006468 | |
| Psa1g5085 | 1007 | Gene3D | Ribonuclease Inhibitor | 26 | 132 | IPR032675 | - | |
| Psa1g5085 | 1007 | Gene3D | Ribonuclease Inhibitor | 220 | 279 | IPR032675 | - | |
| Psa1g5085 | 1007 | PANTHER | UNNAMED PRODUCT | 7 | 975 | - | - | |
| Psa1g5085 | 1007 | SUPERFAMILY | L domain-like | 356 | 619 | - | - | |
| Psa1g5085 | 1007 | SMART | serkin_6 | 696 | 944 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Psa1g5085 | 1007 | SUPERFAMILY | Protein kinase-like (PK-like) | 687 | 966 | IPR011009 | - | |
| Psa1g5085 | 1007 | SUPERFAMILY | RNI-like | 71 | 436 | - | - | |
| Psa1g5085 | 1007 | Gene3D | Transferase(Phosphotransferase) domain 1 | 773 | 985 | - | - | |
| Psa1g5085 | 1007 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 817 | 829 | IPR008271 | GO:0004672|GO:0006468 |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Psa1g5085 | Psa-Chr1 | 370293248 | 370297555 | Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Psa1g5085 | 16 | 998 | Receptor kinase-like Gene Family | AT5G65700 | 55.856 | 0.0 | 1075 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XI-1 | Psa1g5085 | PK_Tyr_Ser-Thr | 1.8e-44 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Psa1g5085 | - | - | cit:102612034 | 1431 |